Label Changes for:

Inlyta (axitinib) tablets

September 2013

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

September 2013

6 ADVERSE REACTIONS  

  • added.....glossodynia
  • addition of adverse drug reactions (Table 1) 
  • addition of hypercalcemia  (Table 2)
Hide
(web3)